Brolucizumab, Alternating Anti-VEGFs Extends nAMD Treatment Intervals HCP Live, 06 Dec 2023 Joseph M. Coney, MD Credit: American Society of Retina Specialists Switching to brolucizumab alone or brolucizimab with…